Molecular analysis of sporadic cases with primary congenital glaucoma:  preliminary study.

M Carmen Chima-Galán; Luz M González-Huerta; María R Rivera-Vega; Cristina Villanueva; Ignacio Babayán-Mena; Olga M Messina-Baas; Sergio A Cuevas-Covarrubias

2005, Number 6

Rev Mex Oftalmol 2005; 79 (6)

Molecular analysis of sporadic cases with primary congenital glaucoma: preliminary study.

Chima-Galán MC, González-Huerta LM, Rivera-Vega MR, Villanueva C, Babayán-Mena I, Messina-Baas OM, Cuevas-Covarrubias SA

Full text

How to cite this article

Language: Spanish
References: 27
Page: 313-317
PDF size: 75.26 Kb.

ABSTRACT

Primary congenital glaucoma (PCG), an autosomal recessive disorder due to abnormal development of the anterior eye portion, is an important cause of childhood blindness. The principal molecular defect in most of PCG subjects occurs in the CYP1B1 gene which is also expressed in the anterior chamber angle of the eye. CYP1B1 enzyme is able to metabolize steroid hormones and participates in tissue development. In the present study, we analyze the CYP1B1 gene of 14 non-related and sporadic patients with PCG. Onset of clinical symptoms ranged from birth to 12 months (mean 4.5 months), the male:female ratio was 10:4 while ocular findings were similar in all patients, two cases were of difficult control. Consanguinity was observed in 3 families. DNA sequencing analysis of the CYP1B1 gene showed no missense or nonsense mutations, only polymorphic changes similar to those observed in normal controls were found to be present. These data allow to conclude that sporadic cases with PCG are not consequence of mutations in the CYP1B1 gene in our population, at least in the analyzed sample. The analysis of the CYP1B1 gene is very important in diagnosis and genetic counseling of PCG in this population.

REFERENCES

1. Broughton WL, Fine BS, Zimmerman LE. Congenital glaucoma associated with a chromosomal defect. A histologic study. Arch Ophthalmol 1981; 99:481-486.
2. Sunden SLF, Alward WLM, Nichols BE y col. Fine mapping of the autosomal dominant juvenile open angle glaucoma (GLC1A) region and evaluation of candidate genes. Genome Res 1996; 6:862-869.
3. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 1997; 6: 641-647.
4. Bejjani BA, Lewis RA, Tomey KF y col. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998; 62:325-333.
5. Plasilova M, Stoilov I, Sarfarazi M y col. Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma. J Med Genet 1999; 36:290-294.
6. Kakiuchi-Matsumoto T, Ishashiki Y, Ohba N y col. Cytochrome P450 1B1 gene mutations in Japanese patients with primary congenital glaucoma. Am J Ophthalmol 2001; 131:345-350.
7. Stoilov IR, Costa VP, Vasconcellos JP y col. Molecular genetics of primary congenital glaucoma in Brazil. Invest Ophthalmol Vis Sci 2002; 43:1820-1827.
8. Sitorus R, Ardjo SM, Lorenz B, Preising M. CYP1B1 gene analysis in primary congenital glaucoma in Indonesian and European patients. J Med Genet 2003; 40: e9.
9. Colomb E, Kaplan J, Garchon HJ. Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France. Hum Mutat 2003; 22:496.
10. Sutter TR, Tang YM, Hayes CL y col. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994; 269:13092-13099.
11. Shimada T, Hayes CL, Yamazaki H y col. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996; 56: 2979-2984.
12. Jimenez-Vaca AL, Valdes-Flores, Rivera-Vega MR y col. Deletion pattern of the STS gene in X-linked ichthyosis in a Mexican population. Mol Med 2001; 7:845-849.
13. Stoilov I, Akarsu AN, Alozie I y col. Sequence analysis and homology modeling suggest primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region of the conserved core structures of cytochrome P450 1B1. Am J Hum Genet 1998; 62:573-584.
14. Reddy AB, Panicker SG, Mandal AK y col. Identification of R368H as a predominant CYP1B1 allele causing primary congenital glaucoma in Indian patients. Invest. Ophthalmol Vis Sci 2003; 44:4200-4203.
15. Soley GC, Bosse KA, Flikier D y col. Primary congenital glaucoma: a novel single-nucleotide deletions and variant phenotypic expression for the 1,546-1,1555dup mutations in the GLC3A (CYP1B1) gene in 2 families of different ethnic origin. J Glaucoma 2003; 12:27-30.
16. Fingert JH, Heon E, Liebmann JM y col. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999; 8:899-905.
17. Baird PN, Craig JE, Richardson AJ y col. Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder affect for the Q368STOP mutation of the myocilin gene in primary open angle glaucoma. Hum Genet 2003; 112:110-116.
18. Adam MF, Belmouden A, Binisti P y col. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 1997; 6:2091-2097.
19. Vincent AL, Billingsley G, Buys Y y col. Digenic inheritance of early-onset glaucoma:CYP1B1, a potential modifier gene. Am J Hum Genet 2002; 70:448-460.
20. Bejjani BA, Stockton DW, Lewis RA y col. Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet 2000; 9:367-374.
21. Aklillu E, Oscarson M, Hidestrand M y col. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Mol Pharmacol 2002; 61:586-594.
22. Abul-Hajj YJ, Cisek PL. Catechol estrogen adducts. J Steroid Biochem 1988; 31:107-110.
23. Liehr JG. Genotoxic effects of estrogens. Mutat Res 1990; 238:269-276.
24. Hanna IH, Dawling S, Roodi N. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000; 60:3440-3444.
25. Watanabe J, Shimada T, Gillam EM y col. Association of CYP1B1 genetic polymorphism with incidence to breast cancer and lung cancer. Pharmacogenetics 2000; 10:25-33.
26. Zheng W, Xie DW, Jin F y col. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:147-150.
27. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphisms with steroid receptor status in breast cancer. {Erratum: Cancer Res. 59:1388, 1999} Cancer Res 1998; 58: 5038-5041.